Showing results (1-10 of 164) with videos related to
Sort By:
Pageof 17
Archives of Pathology & Laboratory Medicine|August 17, 2022
Spindle Cell Lesions of the Breast: A Diagnostic AlgorithmYunbi Ni, Gary M TseSeminars in Diagnostic Pathology|June 19, 2022
Papillary lesions of the breast - review and practical issuesYunbi Ni, Gary M TseThe Oncologist|April 5, 2022
Combining Analysis of Tumor-infiltrating Lymphocytes (TIL) and PD-L1 Refined the Prognostication of Breast Cancer SubtypesYunbi Ni, Julia Y Tsang, Yan Shao, et al.The Oncologist|July 25, 2023
Spatial Distribution and Densities of CD103+ and FoxP3+ Tumor Infiltrating Lymphocytes by Digital Analysis for Outcome Prediction in Breast CancerRonald Chan, Chaiwat Aphivatanasiri, Ivan K Poon, et al.Archives of Pathology & Laboratory Medicine|July 30, 2016
Immunohistochemical Surrogates for Molecular Classification of Breast Carcinoma: A 2015 UpdatePing Tang, Gary M TseHuman Pathology|May 29, 2025
Best pathology practices for HER2 testing interpretation, including HER2-low and ultralow, in the era of HER2-directed antibody drug conjugates (ADCs), aligned with the 2018 CAP/ASCO HER2 guidelinesMonalyn Marabi, Gary M TseModern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|February 3, 2021
Breast cancer with neuroendocrine differentiation: an update based on the latest WHO classificationJulia Y Tsang, Gary M TseHistopathology|December 5, 2022
Update on triple-negative breast cancers - highlighting subtyping update and treatment implicationJulia Y Tsang, Gary M TseBreast Cancer Research and Treatment|June 8, 2010
Diagnosing breast lesions by fine needle aspiration cytology or core biopsy: which is better?Gary M Tse, Puay-Hoon TanHistopathology|January 16, 2016
Pathological criteria and practical issues in papillary lesions of the breast - a reviewYun-Bi Ni, Gary M TsePageof 17